Skip to main navigation Skip to search Skip to main content

Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial

  • Dae Won Lee
  • , Kyung Hae Jung
  • , Kyung Hun Lee
  • , Yeon Hee Park
  • , Keun Seok Lee
  • , Joohyuk Sohn
  • , Hee Kyung Ahn
  • , Jae Ho Jeong
  • , Su Jin Koh
  • , Jee Hyun Kim
  • , Han Jo Kim
  • , Kyoung Eun Lee
  • , Hee Jun Kim
  • , Yae Won Yang
  • , Kyong Hwa Park
  • , Jieun Lee
  • , Hye Sung Won
  • , Tae Yong Kim
  • , Seock Ah Im
  • Seoul National University
  • University of Ulsan
  • National Cancer Center Korea
  • Yonsei University
  • Gachon University
  • Soonchunhyang University
  • Ewha Womans University
  • Chung-Ang University
  • Chungbuk National University
  • Korea University
  • The Catholic University of Korea

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science